TKNO

Alpha Teknova Inc. Common Stock (TKNO)

Stock · NASDAQ · Health Care

$7.09as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 26, 2026

Alpha Teknova Shares Rise 7.1% Amid Technical Momentum. Alpha Teknova stock moved 7.1% higher recently, a gain that has raised questions about the sustainability of this strength. The move coincides with a Bollinger Band breakout signal, indicating increased volatility and momentum. While the stock is trading well above its recent support levels, the rapid rise has pushed the RSI into overbought territory, suggesting the pace of gains may be intense.

Active signals

Support level
$4.94
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances

What TKNO's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike47+0.2%51%
Bollinger Band Breakout21+6.3%67%
Bollinger Band BreakdownActive now21-10.9%38%
200-Day Moving Average TouchActive now7-11.8%43%
Any 20-session window (baseline)-0.5%49%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About TKNO

Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, res…

Sector
Health Care
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Employees
158

Fundamentals

1-day range
$7.32$7.84
Market cap
$350.10M
P/E (trailing)
—
P/E (forward)
-40.00
EPS (trailing)
$-0.31
Dividend yield
—
Beta
0.93
Avg. volume
235.5K
52-week range
$1.91$9.48
Next earnings: November 4, 2026 · EPS estimate $-0.05confirmed

How Alpha Teknova Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$40.52MCost of Revenue$27.08M (67%)SG&A$27.07M (67%)R&D$2.20M (5%)Tax$58.0K (0%)TKNO

Source: 10-K filed Mar 2, 2026 · via SEC EDGAR / Finnhub

Gross Profit$13.44M(33%)
Operating Income-$16.98M(-42%)

Forecasts

6 analyst ratings

Buy 85%
Hold 15%
Sell 0%
1-year price forecast
High
$12
+69.3%
Median
$9.5
+34.0%
Low
$8
+12.8%

Alpha Teknova Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • TKNO
    Alpha Teknova Inc. Common Stock
    $7.08
    ▼ 6.84%
    Market cap $350.10MP/E —
    $1.91$9.48
  • MYGN
    Myriad Genetics Inc. Common Stock
    $3.98
    ▼ 8.51%
    Market cap $304.17MP/E —
    $2.74$8.59
  • IMDX
    Insight Molecular Diagnostics Inc. Common Stock
    $3.01
    ▼ 1.63%
    Market cap $154.99MP/E —
    $2.42$8.51
  • ICCC
    ImmuCell Corporation Common Stock
    $10.75
    ▲ 1.80%
    Market cap $99.70MP/E 121.11
    $4.52$12.1
  • ACHV
    Achieve Life Sciences Inc. Common Shares
    $6.38
    ▼ 8.46%
    Market cap $672.42MP/E —
    $2.62$8.64
  • QCLS
    Q/C Technologies Inc. Common Stock
    $0.538
    ▼ 3.58%
    Market cap $21.99MP/E —
    $0.4201$8.17
  • VNRX
    VolitionRX Limited Common Stock
    $0.18
    ▼ 5.26%
    Market cap $9.23MP/E —
    $0.18$10.31

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
165.0K
Disposed
12.0K

Institutional Ownership

March 31, 2026

Total shares held
7.47M
Total value held
$21.60M
Institutional holders
73
Top holders this quarter
  • Unknown1.88M
  • Unknown1.07M
  • Unknown716.8K
  • Unknown447.1K
  • Unknown441.9K
  • Unknown325.2K
  • Unknown317.1K
  • Unknown307.9K
  • Unknown228.3K
  • Unknown200.0K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.